• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Finance

4D Pharma collaborates with MSD to develop Live Biotherapeutics for vaccines

October 8, 2019 Microbiome Times

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces that the Company has entered into a research collaboration and option to license agreement with MSD, the tradename of […]

Pharma & Human Health

Researchers unlock potential to use CRISPR to alter the microbiome

October 8, 2019 Microbiome Times

Researchers at Western University have developed a new way to deliver the DNA-editing tool CRISPR-Cas9 into microorganisms in the lab, providing a way to efficiently launch a targeted attack on specific bacteria. Published in Nature […]

Pharma & Human Health

Bacteria can be used to heal aspirin-induced ulcers: Irish research reveals

October 7, 2019 Microbiome Times

Aspirin is one of the oldest drugs, widely used for pain relief, suppression of inflammation and prevention of heart disease and stroke. However, well known to many patients is a troublesome side effect of intestinal […]

Pharma & Human Health

Biomica Advances to Pre-Clinical Studies in its IBD Program

October 4, 2019 Microbiome Times

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) and (TASE: EVGN), announces the initiation of pre-clinical studies for BMC321 & BMC322, two rationally-designed microbial consortia aimed […]

Finance

Evolve BioSystems Jointly Files Patent Infringement Complaint Against Abbott Laboratories

October 1, 2019 Microbiome Times

Evolve BioSystems and the Regents of the University of California have jointly filed and served a patent infringement complaint against Abbott Laboratories. The complaint regards Abbott’s soon-to-be-launched product Similac Probiotic Tri-Blend. Evolve BioSystems was founded […]

Animal Health

Chr. Hansen’s good bacteria to be produced on solar power

September 25, 2019 Microbiome Times

A new 10-year agreement enables Chr. Hansen Denmark to switch 100% to green power from two brand new solar parks. The agreement underlines Chr. Hansen’s commitment to a sustainable future and will create more green […]

Finance

Vedanta Biosciences Announces $16.6 Million Series C-2 Financing

September 24, 2019 Microbiome Times

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced a $16.6 million Series C-2 financing round, bringing the total capital […]

Editor's Choice

Interview with Jim Weston and Stephen Conafay of the MTIG

September 22, 2019 Kristina Campbell
Editor's Choice

Babies’ gut bacteria affected by delivery method, Baby Biome project shows

September 19, 2019 Microbiome Times

Babies born vaginally have different gut bacteria – their microbiome – than those delivered by Caesarean, research has shown. Scientists from the Wellcome Sanger Institute, UCL, the University of Birmingham and their collaborators discovered that […]

Pharma & Human Health

The Microbiome Foundation to Fund Academic Research and Raise Public Awareness

September 16, 2019 Microbiome Times

The Microbiome Foundation was created in 2018 with the aim of supporting a genuine scientific revolution. The goal is to promote a new paradigm in healthcare, towards a more personalised and preventative approach that preserves […]

Pharma & Human Health

Developing therapeutic strategies for pregnant women with lupus

September 16, 2019 Microbiome Times

Systemic lupus erythematosus, a chronic autoimmune disease commonly referred to as lupus or SLE, has been compared to volatile, unprovoked brawls within the body. The disease, which has no cure, operates much like an allergic […]

Posts navigation

« 1 … 55 56 57 … 85 »

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter